Keluwih: Jurnal Kesehatan dan Kedokteran https://journal.ubaya.ac.id/index.php/kesdok <p style="text-align: justify;"><strong>Keluwih: Jurnal Kesehatan dan Kedokteran</strong> is an online, open access, and peer-reviewed journal. JKK publishes two issues per year: in December (covering December-May) and in June (covering June-November) First published in December 2019. This journal aims to disseminate the results of original research, case report, and critical reviews in the fields of health and medicine. This focus and scopes include, but are not limited to a pharmacy, medicine, public health, and health biotechnology fields.</p> <p style="text-align: justify;"><br><strong>eISSN:&nbsp;</strong>2715-6419</p> en-US <ul> <li class="show">Articles published in Keluwih: JKK are licensed under a <a title="CC BY SA" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike 4.0 International</a> license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.</li> <li class="show">Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to Kluwih: JKK to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.</li> <li class="show">By publishing in Keluwih: JKK, authors grant any third party the right to use their article to the extent provided by the <a title="CC BY SA" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike 4.0 International</a> license.</li> </ul> singgih_s@staff.ubaya.ac.id (Singgih Sugiarto) rahmanfibri@staff.ubaya.ac.id (Miftahur Rahman Fibri) Mon, 09 Dec 2024 07:09:09 +0000 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 Efektivitas Madu Hutan dan Krim Daun Singkong terhadap Penyembuhan Luka Bakar derajat-IIA https://journal.ubaya.ac.id/index.php/kesdok/article/view/6837 <p style="text-align: justify;"><strong><em>Abstract</em></strong>—<em>The skin is a line of defense in protecting the body from various trauma and injuries such as burns. Grade IIA burns are characterized by red, blistered skin and blisters. Treatment for grade IIA burns generally uses drugs such as sulfadiazine, povidone-iodine, MEBO. prices due to limited drug availability and side effects mean that alternative treatments using traditional ingredients are needed to treat burns. Honey and cassava leaves are traditional ingredients that can be used as an alternative for treating grade IIA burns. This research uses a pure experimental method with post test observations only with control group design. There was a difference in the average length of burn wounds after 14 days of treatment. Forest honey and cassava leaf extract cream are considered effective in healing grade IIA burns. The group of mice given honey had the smallest average length of burn wounds compared to the group given cassava leaf extract cream and followed by the positive control group given silver sulfadiazine and the negative control group without treatment. Thus, forest honey has the greatest effectiveness against grade IIA burns, compared to cassava leaves and the positive control</em><em>.</em><em>&nbsp;</em></p> <p style="text-align: justify;"><strong><em>Keywords:</em></strong> <em>burns, forest honey, cassava leaf cream</em></p> <p style="text-align: justify;">&nbsp;</p> <p style="text-align: justify;"><strong>Abstrak</strong>—Kulit merupakan garis pertahanan dalam melindungi tubuh dari berbagai trauma dan cedera seperti luka bakar. Luka bakar derajat IIA ditandai dengan kulit kemerahan, melepuh dan melepuh. Penanganan luka bakar derajat IIA umumnya menggunakan obat-obatan seperti <em>sulfadiazin, povidone-iodine, MEBO</em>. Harga yang mahal akibat keterbatasan ketersediaan obat dan efek samping menyebabkan diperlukannya pengobatan alternatif dengan bahan-bahan tradisional untuk mengatasi luka bakar. Madu dan daun singkong merupakan bahan tradisional yang dapat digunakan sebagai alternatif penanganan luka bakar derajat IIA. Penelitian ini menggunakan metode <em>eksperimen</em> murni dengan rancangan post test observasi only with control group design. Terdapat perbedaan rerata panjang luka bakar setelah 14 hari perawatan. Krim madu hutan dan ekstrak daun singkong dinilai efektif dalam penyembuhan luka bakar derajat IIA. Kelompok mencit yang diberikan madu memiliki rerata panjang luka bakar paling kecil dibandingkan dengan kelompok yang diberikan krim ekstrak daun singkong dan diikuti oleh kelompok kontrol positif yang diberikan <em>silver sulfadiazine</em> dan kelompok kontrol negatif tanpa pengobatan. Dengan demikian, madu hutan mempunyai efektivitas paling besar terhadap luka bakar derajat IIA dibandingkan dengan daun singkong dan kontrol positif.</p> <p style="text-align: justify;"><strong>Kata kunci:</strong><em> luka bakar, madu hutan, krim daun singkong </em></p> Jonaha Bonafide Tampubolon, Runggu Retno J Napitupulu, Hendra (Author) Copyright (c) 2024 Jonaha Bonafide Tampubolon, Runggu Retno J Napitupulu, Hendra (Author) http://creativecommons.org/licenses/by-sa/4.0 https://journal.ubaya.ac.id/index.php/kesdok/article/view/6837 Mon, 09 Dec 2024 07:07:19 +0000 Hubungan Tingkat Pengetahuan Terhadap Perilaku Swamedikasi Batuk Masyarakat https://journal.ubaya.ac.id/index.php/kesdok/article/view/6029 <p style="text-align: justify;"><em><strong>Abstract</strong>—Self-medication is a way for someone to heal themselves in dealing with complaints such as illness or disease symptoms without using a doctor's prescription. One of the diseases that can be treated with self-medication is cough. This study aims to determine the relationship between knowledge and cough self-medication behavior in the community of RW 23, Serua Village, Ciputat District, South Tangerang City. This research is descriptive-analytical research with a cross-sectional design; research data was taken using a questionnaire. The number of respondents was 255. The sampling technique used Cluster Random Sampling. The research results obtained variable levels of knowledge in the excellent category (60.4%), sufficient category (22.0%), and poor category (17.6%). Behavioral variables in the excellent category (64.3%), sufficient category (18.4%), and poor category (17.3%). There is a relationship between education and income on knowledge of cough self-medication with a p-value of 0.000 &lt; 0.05, so H0 is rejected and H1 is accepted. There is a relationship between the level of knowledge and cough self-medication behavior of the community in RW 23, Serua Village, Ciputat District, South Tangerang City, with a p-value of 0.000 &lt; 0.05, so H0 is rejected, and H1 is accepted.&nbsp;</em></p> <p style="text-align: justify;"><strong><em>Keyword</em><em>s:</em></strong><em> cough, behavior, knowledge, self-medication</em></p> <p style="text-align: justify;">&nbsp;</p> <p style="text-align: justify;"><strong>Abstrak</strong><strong>—</strong>Swamedikasi adalah cara seseorang menyembuhkan diri dalam menangani keluhan seperti penyakit ataupun gejala – gejala penyakit tanpa menggunakan resep dokter. Salah satu penyakit yang dapat dilakukan dengan swamedikasi adalah batuk. Penelitian ini bertujuan untuk mengetahui hubungan antara pengetahuan dan perilaku swamedikasi batuk pada masyarakat RW 23 Kelurahan Serua Kecamatan Ciputat Kota Tangerang Selatan. Penelitian ini merupakan jenis penelitian deskriptif analitik dengan rancangan <em>cross sectional</em>; data penelitian diambil menggunakan kuesioner. Jumlah responden sebanyak 255. Teknik pengambilan sampel menggunakan<em> Cluster Random Sampling. </em>Hasil penelitian diperoleh variabel tingkat pengetahuan dengan kategori baik (60,4%), kategori cukup (22,0%), dan kategori kurang (17,6%). Variabel perilaku dengan kategori baik (64,3%), kategori cukup (18,4%) dan kategori kurang (17,3%). Ada hubungan antara pendidikan dan pendapatan terhadap pengetahuan swamedikasi batuk dengan <em>p-value</em> sebesar 0,000 &lt; 0,05, maka H0 ditolak dan H1 diterima. Ada hubungan antara tingkat pengetahuan terhadap perilaku swamedikasi batuk masyarakat di Wilayah RW 23 Kelurahan Serua Kecamatan Ciputat Kota Tangerang Selatan dengan <em>p-value</em> sebesar 0,000 &lt; 0,05, maka H0 ditolak dan H1 diterima.</p> <p style="text-align: justify;"><strong>Kata kunci:</strong> <em>b</em><em>atuk, </em><em>p</em><em>erilaku</em><em>,</em> <em>p</em><em>engetahuan,</em><em> s</em><em>wamedikasi</em></p> <p style="text-align: justify;"><em>&nbsp;</em></p> Teodhora, Ainun Wulandari, Kinanthi Kusumawardhani (Author) Copyright (c) 2024 Teodhora, Ainun Wulandari, Kinanthi Kusumawardhani (Author) http://creativecommons.org/licenses/by-sa/4.0 https://journal.ubaya.ac.id/index.php/kesdok/article/view/6029 Mon, 09 Dec 2024 09:15:07 +0000 Potensi Terapi Fitokanabinoid Mayor dalam Pengobatan Cedera Otak Traumatik: sebuah Tinjauan Literatur Farmakologis https://journal.ubaya.ac.id/index.php/kesdok/article/view/7071 <p style="text-align: justify;"><strong><em>Abstract</em></strong><strong>—</strong><em>Traumatic brain injury (TBI) is a global health issue that leads to long-term neurological deficits, including cognitive, motor, and mood disorders. Current TBI treatments primarily focus on symptom management, while neuroprotective therapies remain in the exploratory stage. One promising approach is the use of Cannabis sativa L., which contains phytocannabinoids, compounds with potential neuroprotective effects. Preclinical studies have shown that the major phytocannabinoids, cannabidiol (CBD) and tetrahydrocannabinol (THC), may have neuroprotective effects in TBI through mechanisms such as reducing excitotoxicity, neuroinflammation, and oxidative stress. These major phytocannabinoids are known to influence cannabinoid receptors (CB1 and CB2), which play roles in modulating inflammatory processes, reducing neuronal damage, improving motor and cognitive functions, and regulating recovery mechanisms in the blood-brain barrier and intracranial lymphatics. This review aims to explore the therapeutic potential of major phytocannabinoids in TBI treatment by highlighting the pathophysiological mechanisms of TBI and the neuroprotective effects of these compounds. A deeper understanding of the mechanisms of action of phytocannabinoids may pave the way for the development of phytocannabinoid-based therapies for TBI in the future.</em></p> <p style="text-align: justify;"><strong><em>Keywords:</em></strong> &nbsp;<em>traumatic brain injury, neuroprotection,&nbsp;</em><em>cannabis sativa</em><em>&nbsp;l., major phytocannabinoids, cannabidiol, tetrahydrocannabinol</em></p> <p style="text-align: justify;"><strong>&nbsp;</strong></p> <p style="text-align: justify;"><strong>Abstrak</strong><strong>—</strong>Cedera otak traumatik (COT) merupakan masalah kesehatan global yang menyebabkan defisit neurologis jangka panjang, termasuk gangguan kognitif, motorik, dan suasana hati. Pengobatan COT saat ini lebih difokuskan pada manajemen gejala, sementara pengobatan yang bersifat neuroprotektif masih dalam tahap eksplorasi. Salah satu pendekatan yang menjanjikan adalah penggunaan tanaman <em>Cannabis sativa</em> L. yang mengandung fitokanabinoid, senyawa yang memiliki potensi neuroprotektif. Metode yang digunakan adalah kajian literatur. Hasil kajian penelitian preklinik menunjukkan bahwa fitokanabinoid mayor yaitu kanabidiol (KBD) dan tetrahidrokanabinol (THC) dapat memberikan efek neuroprotektif pada COT melalui mekanisme pengurangan eksitotoksisitas, neuroinflamasi, dan stres oksidatif. Senyawa fitokanabinoid mayor diketahui mempengaruhi reseptor kanabinoid (RKB1 dan RKB2), yang berperan dalam modulasi proses inflamasi, pengurangan kerusakan neuron dan dapat memperbaiki fungsi motorik dan kognitif, serta mengatur mekanisme pemulihan pada sawar darah-otak dan limfatik intrakranial. Hasil kajian literatur menunjukkan bahwa tanaman <em>Cannabis sativa</em> L. yang mengandung fitokanabinoid mayor memiliki potensi dalam pengobatan COT. Pemahaman yang lebih dalam tentang mekanisme kerja fitokanabinoid dapat membuka jalan bagi pengembangan terapi berbasis fitokanabinoid untuk COT di masa depan.</p> <p style="text-align: justify;"><strong><em>Kata kunci</em></strong><strong><em>:</em></strong> &nbsp;<em>cedera otak traumatis, neuroproteksi,&nbsp;</em><em>cannabis sativa</em><em>&nbsp;l., fitokanabinoid mayor, kanabidiol, tetrahidrokanabinol</em></p> Arief Gunawan Darmanto (Author) Copyright (c) 2024 Arief Gunawan Darmanto (Author) http://creativecommons.org/licenses/by-sa/4.0 https://journal.ubaya.ac.id/index.php/kesdok/article/view/7071 Tue, 31 Dec 2024 00:00:00 +0000 Anticancer Activity of Asiatic Acid from Centella Asiatica: A Comprehensive Systematic Review of In Vitro and In Vivo Studies https://journal.ubaya.ac.id/index.php/kesdok/article/view/6752 <p style="text-align: justify;"><strong><em>Abstract</em></strong>—<em>Centella asiatica, containing asiatic acid (AsA), represents one such candidate demonstrating promising anticancer effects. This study aims to comprehensively review the anticancer activity of AsA in published in vitro and in vivo studies. A systematic review method was employed and several databases, including Scopus, PubMed, ScienceDirect, and Google Scholar, were used to conduct a comprehensive and systematic search of the literature based in vitro and in vivo studies in November 2023 following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Thirty-three articles were included, distributed across twenty-five in vitro studies, three in vivo studies, and five both in vitro and in vivo studies. Based on the findings in the reviewed articles, we report that AsA, a triterpene derived from C. asiatica, exhibits anticancer effects demonstrated both in various cancer cell lines and in cancer cell-induced animal model, through several mechanisms, including anti-inflammatory effects, antioxidant effects, inhibition of cell proliferation, inhibition of invasion and migration, and induction of apoptosis and autophagy. Conclusions based on findings in in vitro and in vivo studies, AsA has strong potential to be used and developed as an inhibitor of various types of cancer cells.</em></p> <p style="text-align: justify;"><strong><em>Keywords:</em></strong> <em>anticancer, asiatic acid, cancer, centella asiatica, herbal</em></p> <p style="text-align: justify;">&nbsp;</p> <p style="text-align: justify;"><strong>Abstrak</strong>—<em>Centella asiatica</em>, yang mengandung asam asiatik (AsA), mewakili salah satu kandidat yang menunjukkan efek antikanker yang menjanjikan. Penelitian ini bertujuan untuk meninjau secara komprehensif aktivitas antikanker AsA dalam studi<em> in vitro</em> dan <em>in vivo</em>. Metode yang digunakan adalah tinjauan sistematis pada beberapa basis data, termasuk Scopus, PubMed, ScienceDirect, dan Google Scholar, untuk melakukan pencarian literatur yang komprehensif dan sistematis berdasarkan studi<em> in vitro</em> dan <em>in vivo</em> yang dilakukan pada November 2023 dan mengikuti pedoman <em>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</em> (PRISMA). Tiga puluh tiga artikel diinklusikan, terdiri dari dua puluh lima studi <em>in vitro,</em> tiga studi <em>in vivo</em>, dan lima studi <em>in vitro</em> dan <em>in vivo</em>. Berdasarkan temuan dalam artikel yang ditinjau, kami melaporkan bahwa AsA, triterpen yang berasal dari <em>C. asiatica</em>, menunjukkan efek antikanker baik di berbagai sel kanker maupun pada model hewan yang diinduksi sel kanker, melalui beberapa mekanisme, termasuk efek antiinflamasi, efek antioksidan, penghambatan proliferasi sel, penghambatan invasi dan migrasi, serta induksi apoptosis dan autofagi. Kesimpulan berdasarkan temuan dalam studi <em>in vitro</em> dan <em>in vivo</em>, AsA memiliki potensi yang kuat untuk digunakan dan dikembangkan sebagai penghambat berbagai jenis sel kanker.</p> <p style="text-align: justify;"><strong>Kata kunci:</strong><em> antikanker, asam asiatik, kanker, centella asiatica, herbal</em></p> Fiki Muhammad Ridho, Panggih Fahrudin, Andika Julyanto Syachputra, Iren Angelia Aruan, Kamailiya Ulfah, Alfi Syahri (Author) Copyright (c) 2024 Fiki Muhammad Ridho, Panggih Fahrudin, Andika Julyanto Syachputra, Iren Angelia Aruan, Kamailiya Ulfah, Alfi Syahri (Author) http://creativecommons.org/licenses/by-sa/4.0 https://journal.ubaya.ac.id/index.php/kesdok/article/view/6752 Tue, 31 Dec 2024 00:00:00 +0000 Curcuminoid Compounds Inhibit Macrophage Migration Inhibitory Factor: In Silico Study for Their Association to Anti-diabetic Potency https://journal.ubaya.ac.id/index.php/kesdok/article/view/7345 <p style="text-align: justify;"><strong><em>Abstract</em></strong>—<em>Diabetes mellitus is a health problem characterized by chronic inflammation causing complications in the cardiovascular, kidneys, eyes, and nervous system, with macrophage migration inhibitory factor (MIF) protein playing a crucial function in the inflammatory process chain. MIF has been known as a signaling protein involved in the development of type 1 and type 2 diabetes mellitus (DM). There are several studies indicating that the development of type 1 and type 2 DM is influenced by the accumulation of macrophages in tissues susceptible to diabetic injury or infection. Curcuminoids, the bioactive components in turmeric, are known for their ability to decrease inflammation. This in silico study is intended to analyze the potential anti-inflammatory effect of curcuminoid in DM, with a specific focus on how it may reduce proinflammatory signals through MIF. The investigation involved predicting physicochemical, pharmacokinetic and toxicity (ADMET) qualities for curcuminoids, followed by molecular docking simulations with MIF as the target protein.</em> <em>The ADMET results showed curcumin and bisdemethoxycurcumin had favorable properties, while dimethoxycurcumin exhibited undesirable traits like low VDss. Therefore, molecular docking simulations were performed using curcumin and bisdemethoxycurcumin as ligands. The molecular docking simulations indicated that curcumin has a negative binding affinity slightly lower than (S, R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), a reference MIF inhibitor; and bisdemethoxycurcumin binds to MIF even stronger than ISO-1, with interacting MIF amino acids Lys 32, Ile 64 Asn 97, Pro 1, and Tyr 95. Hence, the curcumin and bisdemethoxycurcumin compounds were found as having the potential to inhibit MIF activity that is associated with the progression of DM.</em>&nbsp;</p> <p style="text-align: justify;"><strong><em>Keyword</em><em>s:</em></strong><em> curcuminoids, diabetes melitus (dm),</em> <em>inflammation, mif inhibitors, molecular docking </em></p> <p style="text-align: justify;">&nbsp;</p> <p style="text-align: justify;"><strong><em>Abstrak</em></strong>—Diabetes mellitus (DM) merupakan masalah kesehatan yang ditandai dengan peradangan kronis, yang dapat menyebabkan komplikasi pada sistem kardiovaskular, ginjal, mata, dan sistem saraf. Protein macrophage migration inhibitory factor (MIF) memiliki peran penting dalam proses peradangan. MIF diketahui sebagai protein pensinyalan yang terlibat dalam perkembangan DM tipe 1 dan tipe 2. Beberapa penelitian menunjukkan bahwa perkembangan DM tipe 1 dan tipe 2 dipengaruhi oleh akumulasi makrofag pada jaringan yang rentan terhadap cedera atau infeksi akibat diabetes. Kurkuminoid, komponen bioaktif dalam kunyit, dikenal memiliki kemampuan untuk meringankan peradangan. Studi <em>in silico</em> ini bertujuan untuk menganalisis potensi efek antiinflamasi kurkuminoid terhadap DM, dengan fokus pada kemampuannya dalam menurunkan sinyal proinflamasi melalui MIF. Studi ini mencakup prediksi sifat fisikokimia, farmakokinetik, dan toksisitas (ADMET) kurkuminoid, yang dilanjutkan dengan simulasi <em>molecular docking</em> menggunakan MIF sebagai protein target. Hasil analisis ADMET menunjukkan bahwa kurkumin dan bisdemetoksikurkumin memiliki sifat yang menguntungkan, sedangkan dimetoksikurkumin menunjukkan karakteristik yang kurang diinginkan, seperti volume distribusi (VDss) yang rendah. Oleh karena itu, simulasi <em>molecular docking</em> dilakukan dengan menggunakan kurkumin dan bisdemetoksikurkumin sebagai ligan. Hasil simulasi <em>molecular docking</em> menunjukkan bahwa kurkumin memiliki afinitas pengikatan yang sedikit lebih rendah dibandingkan dengan <em>(S, R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1)</em>, senyawa referensi inhibitor MIF. Sementara itu, bisdemetoksikurkumin menunjukkan ikatan yang lebih kuat dengan MIF dibandingkan ISO-1, dengan residu asam amino MIF yang berinteraksi meliputi Lys 32, Ile 64, Asn 97, Pro 1, dan Tyr 95. Dengan demikian, senyawa kurkumin dan bisdemetoksikurkumin berpotensi menghambat aktivitas MIF yang berperan dalam perkembangan DM. &nbsp;</p> <p style="text-align: justify;"><strong>Kata kunci</strong><strong>:</strong> kurkuminoid, diabetes melitus (dm), peradangan, inhibitor mif, molecular docking<em>.</em></p> Graciana Alves de Jesus, Tjie Kok Go (Author) Copyright (c) 2024 Graciana Alves de Jesus, Tjie Kok Go (Author) http://creativecommons.org/licenses/by-sa/4.0 https://journal.ubaya.ac.id/index.php/kesdok/article/view/7345 Wed, 19 Feb 2025 09:05:52 +0000